May 8, 2025, 08:29 by

Elegen expanded it's ENFINIA cell-free gene synthesis platform with the launch of an early access program for IVT Ready DNA targeted toward RNA therapeutics, cell and gene therapies, and personalized cancer vaccines. ENFINIA IVT Ready DNA offers full-length, high-complexity, high-accuracy linear DNA with a long poly(A) tail, manufactured cell-free and delivered in as few as 10 days, ready for immediate use to speed genetic medicine development.

May 8, 2025, 08:29 by

GenNext® Technologies, Inc. is collaborating with Thermo Fisher Scientific to provide a simplified structural biology workflow designed to improve biotherapeutic development

May 8, 2025, 08:29 by

Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies, supporting the development of more targeted treatment decisions and advancing pharmaceutical R&D.

May 8, 2025, 01:00 by User Not Found

Clinical Research News | A diagnosis of amyotrophic lateral sclerosis (ALS) is devastating news given to about 5,000 people in the U.S. each year. It is a rare central nervous system disease without a cure that relentlessly progresses, although death variably occurs anywhere from a few months to many years after symptoms first become noticeable.

May 7, 2025, 14:24 by

Gifthealth, a technology-driven pharmacy care company dedicated to making prescription access easier and more affordable, is pleased to announce the appointment of Chip Parkinson as its new Chief Executive Officer.

May 7, 2025, 08:22 by

May 7, 2025, 08:22 by

May 6, 2025, 08:37 by

May 6, 2025, 01:00 by User Not Found

Clinical Research News | At last month’s Bio-IT World Conference & Expo, Joan Chambers, Senior Consultant at Tufts Center for the Study of Drug Development (CDSS), spoke extensively about the future of clinical trials, particularly on the impact of decentralized clinical trials (DCTs), approaches that improve accessibility and convenience for the trial process, and insights on solutions for patient recruitment and retention.

May 1, 2025, 08:40 by

May 1, 2025, 08:39 by

New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows.

Apr 30, 2025, 01:00 by User Not Found

Clinical Research News | FYR announced a collaboration with Mayo Clinic seeking to advance the use of blood-based biomarkers in Parkinson’s disease research and clinical applications; BioProcess360 Partners announced the formation of ChromaGenix, a new biotechnology company focused on advancing downstream purification technologies for emerging biotherapeutics; Flatiron Health announced a strategic partnership with Massive Bio to expand patient identification capabilities and improve clinical trial enrollment across the US; and more.

Apr 29, 2025, 01:00 by User Not Found

Clinical Research News | AIRNA will further develop its AIR-001 to address AATD by targeting and repairing the SERPINA1 mutation in the RNA transcript; Glycomine will advance its lead candidate, GLM101, into a Phase 2b clinical trial for a rare and life-threatening genetic disorder with no approved treatments; and more.

Apr 25, 2025, 08:14 by

EpiCypher® has announced the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery.

Apr 25, 2025, 08:14 by

Aplos NCA includes new features to support custom data processing, flexible table and figure creation, and the ability to create custom reports using user-defined templates.

Apr 25, 2025, 01:00 by User Not Found

Clinical Research News | Pharmaceutical companies and regulators are increasingly aligning around the need to better incorporate patient preferences into clinical trial design. This shift stems from a broader movement to measure whether treatments are efficacious on terms that are also valuable from the patient’s perspective.

Apr 24, 2025, 08:30 by

Apr 24, 2025, 08:30 by

Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation

Apr 24, 2025, 08:30 by

The extensive body of research from Mayo Clinic emphasizes major advancements in obesity, including prediction of GLP-1 side effects, a new obesity sub-phenotype, and insights into personalized bariatric and endoscopic procedures.

Apr 24, 2025, 01:00 by User Not Found

Clinical Research News | Pharma companies and academic institutions are key players in drug development but operate in disconnected ecosystems. Universities are constantly developing highly innovative drug screening models, while industry has many promising molecules and drug compounds, yet the two worlds more often collide than collaborate to get needed medicines to patients faster.